Carbetocin RTS

The WHO is funding a Clinical Trial beginning May 2015 and expected to run for 18 months. The research will be conducted at Frere Maternity and Cecilia Makiwane Hospitals in East London, Eastern Cape, South Africa

A phase III randomized, double-blinded, active, controlled, multinational, multicentre, non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrage during the third stage of labour in women delivering vaginally.